Skip to main content
. 2015 Mar 29;23(11):3131–3140. doi: 10.1007/s00520-015-2686-9

Fig. 2.

Fig. 2

Overview of data from randomized controlled trials on G-CSF PP included in the meta-analysis of all chemotherapy cycles without adjustment for relative dose intensity (n = 30). G-CSF granulocyte colony-stimulating factor, PP primary prophylaxis